Early biomarkers for predicting sepsis-induced shock: insights from inflammatory pathways and immune response
Year: 2026
Type: article
Abstract: Severe sepsis-induced shock is one of the most challenging problems in critical care despite the progress made in treatment. Recognizing high-risk patients early on is critical for successful results, and the standard diagnostic approaches to such an ailment fail to identify it prior to shock setting in. Biomarkers have become promising diagnostic, prognostic predictors and treatment surveillance platforms in sepsis in the past few years. This review discusses the significance of biomarkers, e.g., cytokines, chemokines, acute-phase proteins and immune dysfunction markers in the pathogenesis of sepsis-induced shock. Additionally, we investigate the potential of new biomarkers, including microRNAs, circular RNAs, endothelial biomarkers, gene signatures, a combination of multimarker panels and machine learning models to improve the diagnostic and prognostic proficiency. As effective as they may seem, they (biomarkers) create challenges in clinical application, including variability, standardization, cost and regulatory approval. This review discusses future approaches to sepsis biomarker research, focusing on personalized medicine, global availability, and clinical validation to address barriers currently experienced in improving sepsis management worldwide.
Source: Frontiers in Pharmacology
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7133644242